These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2510433)

  • 1. Multiple myeloma: beta-2-microglobulin is not a useful follow-up parameter.
    Boccadoro M; Omedè P; Frieri R; Battaglio S; Gallone G; Massaia M; Redoglia V; Pileri A
    Acta Haematol; 1989; 82(3):122-5. PubMed ID: 2510433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system.
    Bataille R; Boccadoro M; Klein B; Durie B; Pileri A
    Blood; 1992 Aug; 80(3):733-7. PubMed ID: 1638024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
    Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
    Scarffe JH; Anderson H; Palmer MK; Crowther D
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients.
    Bataille R; Grenier J; Sany J
    Blood; 1984 Feb; 63(2):468-76. PubMed ID: 6362753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
    Bataille R; Grenier J
    Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta-2-microglobulin (beta 2m) in myeloma: toward a simple prognostic stratification using beta 2M and acute-phase proteins?
    Bataille R; Klein B
    Blood; 1991 Apr; 77(7):1616-7. PubMed ID: 1706956
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
    Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
    Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
    Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
    Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
    Linkesch W; Ludwig H
    Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
    Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
    Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected normal serum beta-microglobulin (B2M) levels in multiple myeloma.
    Bataille R; Grenier J; Sany J
    Anticancer Res; 1987; 7(3 Pt B):513-5. PubMed ID: 3307602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum beta 2-microglobulin levels in multiple myeloma and monoclonal gammapathy of undetermined significance: a clinical study of 55 patients.
    Chelazzi G; Senaldi G
    Ric Clin Lab; 1986; 16(1):53-8. PubMed ID: 3090677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum beta 2-microglobulin in multiple myeloma.
    Brenning G; Simonsson B; Källander C; Ahre A
    Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.